CRI Genetics Settlement is a Lesson in Ethical Marketing for the DNA Testing Industry

CRI Genetics Settlement is a Lesson in Ethical Marketing for the DNA Testing Industry

CRI Genetics, a California-based DNA testing firm, has been ordered to pay a $700,000 civil penalty by the Federal Trade Commission (“FTC”) and California Attorney General’s Office for misleading practices that misrepresented the accuracy of its DNA ancestry reports. This case highlights the importance of transparency and integrity in genetic testing marketing strategies.

The complaint against CRI Genetics was multifaceted, focusing on a range of deceptive tactics aimed at enticing consumers to purchase DNA test kits. Allegations included claims that its ancestry reports were superior to those of established competitors like Ancestry DNA and 23andMe, asserting an accuracy rate of over 90%. Such inflated claims not only mislead consumers but also risk undermining trust in an industry already fraught with skepticism.

Moreover, CRI Genetics employed “dark patterns” in its online billing process, creating a confusing user experience designed to compel purchases without informed consent. Consumers were funneled through a maze of pop-up pages promising special rewards, only to find that their orders were not complete until they were charged. This lack of clarity can lead to unintentional financial commitments, further complicating the relationship between consumers and companies in the DNA testing field.

The settlement mandates a complete overhaul of CRI’s marketing practices. Moving forward, the company is prohibited from making any unsubstantiated claims regarding its products, including those related to accuracy, endorsements, and reviews. This measure aims to ensure that consumers are not only well-informed but also empowered to make decisions based on accurate information.

Additionally, the order requires CRI Genetics to provide clear disclosures about the total costs of products, the timing of charges, and the options consumers have to confirm or change their orders before being billed. This transparency is critical in fostering a fair marketplace where consumers feel secure in their purchasing decisions.

One of the most significant aspects of the settlement involves the handling of biometric information. CRI Genetics is now obligated to respect consumers’ rights regarding their data. This includes allowing customers to delete their genetic information upon request. In an era where personal data is often exploited, such protections are essential for maintaining consumer trust and ensuring ethical business practices.

For other companies operating in the DNA testing and biometric information sectors, this settlement serves as a wake-up call. The FTC’s actions signal a broader commitment to scrutinizing misleading marketing claims and unfair practices, particularly those that exploit vulnerable consumers. Businesses must recognize that ethical marketing is not just a regulatory obligation but also a pathway to long-term success.

Companies should prioritize building trust through transparent communication, accurate representations of their products, and a strong commitment to consumer privacy. Engaging in honest marketing not only enhances a brand’s reputation but can also foster loyalty and repeat business.

In light of the recent FTC action against CRI Genetics, companies in the genetic testing sector, and beyond, have critical lessons to take away regarding ethical marketing practices and consumer protection compliance.

First and foremost, it’s essential for all companies, particularly those operating in emerging markets like home genetics testing, to understand that established truth-in-advertising standards are applicable regardless of how new the industry may be. Companies are responsible for adhering to well-established consumer protection principles, which include substantiating any claims that suggest superiority over competitors. The CRI Genetics case is a clear reminder that scrutiny from law enforcement agencies is increasing, and businesses must prepare accordingly.

Furthermore, the use of misleading reviews and endorsements is strictly prohibited. The FTC has a long history of enforcing laws against bogus review sites and fabricated testimonials. Companies must ensure their marketing practices are transparent and genuine, as deceptive tactics can lead to significant legal consequences. The FTC provides clear resources on endorsements and reviews, emphasizing the importance of honesty in marketing efforts.

Additionally, companies should avoid complicating the purchasing process with confusing tactics designed to extract more money from consumers without their informed consent. Deceptive practices that obscure the true nature of charges or require customers to navigate a convoluted series of pop-ups and add-ons are under close scrutiny. Law enforcement agencies, including the FTC and California regulators, are actively working to eliminate these dark patterns. Companies should heed these warnings and simplify the purchasing process to foster trust and transparency.

Lastly, businesses collecting sensitive biometric information must be particularly vigilant. The FTC’s Policy Statement on Biometric Information highlights that the collection of such data comes with heightened obligations. Companies need to clearly communicate how they intend to use or retain sensitive biometric information before it’s collected. Failing to honor these obligations can lead to the necessity of destroying collected data and discontinuing the use of algorithms that rely on this information.

By committing to ethical marketing, transparent consumer interactions, and robust data protection practices, businesses can build a reputation of trustworthiness that not only complies with legal standards but also fosters long-term customer loyalty.

If you would like to read more about this case and others, visit our Case Studies Library.

(Image Credit: iStock Photo)

This article is for information purposes only. It is not intended to be and should not be relied on as legal advice for any particular matter.